Literature DB >> 2066666

Disposition of intracellular cholesterol in human fibroblasts.

Y Lange1.   

Abstract

We have examined the intracellular distribution of unesterified cholesterol in cultured human fibroblasts. Intact cells were treated with cholesterol oxidase to selectively transform cell surface cholesterol to cholestenone. Isopycnic centrifugation of homogenates showed that the cholestenone had a peak buoyant density of 1.13 g/cm3. The approximately 10% of total cholesterol which remained unoxidized was distributed in two peaks of roughly equal size: a sharp peak at approximately 1.09 g/cm3 and a broad peak centered at 1.18 g/cm3. When intact cells were incubated with exogenous [3H]cholesterol, the radiolabel entered the nonoxidizable pool in a temperature-dependent fashion with a half time of 3 h at 37 degrees C. This label initially was associated with the dense but not the buoyant peak of nonoxidized cholesterol. After 40 h, the buoyant peak also became labeled; both peaks then had a specific activity slightly less than the surface cholestenone. The buoyant density of the unoxidized cholesterol did not coincide with markers for the Golgi apparatus, endoplasmic reticulum, or lysosomes. However, two ingested markers of pinocytosis, calcein and horseradish peroxidase, comigrated with the dense peak of unoxidized cholesterol. That the size of the unoxidized cholesterol pool was greater in cells deprived of serum lipoproteins than in fed cells suggested that none of the intracellular cholesterol need be ascribed to ingested sterols. The mass of unoxidizable cholesterol was not diminished when cholesterol biosynthesis was inhibited by lovastatin in lipoprotein-deprived cells. Furthermore, the newly synthesized radiolabeled cholesterol resistant to cholesterol oxidase did not migrate with intracellular cholesterol mass on sucrose density gradients. The newly synthesized cholesterol amounted to about 10% of the total unoxidized sterol. These data indicate that most of the intracellular cholesterol was not newly synthesized. We conclude that a) approximately 90% of fibroblast cholesterol is associated with the cell surface; b) the bulk of intracellular cholesterol, approximately 10% of total, is derived from internalized (endocytic) plasma membrane; and c) the most recently synthesized cholesterol, approximately 1% of the total, is in a discrete organelle.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2066666

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  47 in total

1.  Subcellular localization and topology of the p7 polypeptide of hepatitis C virus.

Authors:  Séverine Carrère-Kremer; Claire Montpellier-Pala; Laurence Cocquerel; Czeslaw Wychowski; François Penin; Jean Dubuisson
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

2.  Topological changes in the transmembrane domains of hepatitis C virus envelope glycoproteins.

Authors:  Laurence Cocquerel; Anne Op de Beeck; Michel Lambot; Juliette Roussel; David Delgrange; André Pillez; Czeslaw Wychowski; François Penin; Jean Dubuisson
Journal:  EMBO J       Date:  2002-06-17       Impact factor: 11.598

Review 3.  Review of progress in sterol oxidations: 1987-1995.

Authors:  L L Smith
Journal:  Lipids       Date:  1996-05       Impact factor: 1.880

4.  Membrane cholesterol modulates the fluid shear stress response of polymorphonuclear leukocytes via its effects on membrane fluidity.

Authors:  Xiaoyan Zhang; Jonathan Hurng; Debra L Rateri; Alan Daugherty; Geert W Schmid-Schönbein; Hainsworth Y Shin
Journal:  Am J Physiol Cell Physiol       Date:  2011-04-27       Impact factor: 4.249

5.  Transmembrane topology of mammalian ORMDL proteins in the endoplasmic reticulum as revealed by the substituted cysteine accessibility method (SCAM™).

Authors:  Deanna Davis; John Suemitsu; Binks Wattenberg
Journal:  Biochim Biophys Acta Proteins Proteom       Date:  2019-01-10       Impact factor: 3.036

6.  Cholesterol loss during glutamate-mediated excitotoxicity.

Authors:  Alejandro O Sodero; Joris Vriens; Debapriya Ghosh; David Stegner; Anna Brachet; Marta Pallotto; Marco Sassoè-Pognetto; Jos F Brouwers; J Bernd Helms; Bernhard Nieswandt; Thomas Voets; Carlos G Dotti
Journal:  EMBO J       Date:  2012-02-17       Impact factor: 11.598

7.  Localization of cholesterol in sphingomyelinase-treated fibroblasts.

Authors:  M I Pörn; J P Slotte
Journal:  Biochem J       Date:  1995-05-15       Impact factor: 3.857

8.  Induction of tissue inhibitor of matrix metalloproteinase-2 by cholesterol depletion leads to the conversion of proMMP-2 into active MMP-2 in human dermal fibroblasts.

Authors:  Sangmin Kim; Jang-Hee Oh; Youngae Lee; Jeongyoon Lee; Kwang Hyun Cho; Jin Ho Chung
Journal:  Exp Mol Med       Date:  2010-01-31       Impact factor: 8.718

Review 9.  High density lipoprotein biogenesis, cholesterol efflux, and immune cell function.

Authors:  Mary G Sorci-Thomas; Michael J Thomas
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-11       Impact factor: 8.311

Review 10.  Use of cyclodextrins to manipulate plasma membrane cholesterol content: evidence, misconceptions and control strategies.

Authors:  Raphael Zidovetzki; Irena Levitan
Journal:  Biochim Biophys Acta       Date:  2007-04-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.